Bellevue Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-65,008
| Closed | -$3.86M | – | 163 |
|
|
2025
Q4 | $3.86M | Sell |
65,008
-36,025
| -36% | -$1.96M | 0.07% | 80 |
|
|
2025
Q3 | $5.47M | Sell |
101,033
-50,412
| -33% | -$2.88M | 0.11% | 74 |
|
|
2025
Q2 | $8.32M | Sell |
151,445
-216,928
| -59% | -$12.8M | 0.18% | 69 |
|
|
2025
Q1 | $26M | Buy |
368,373
+39,352
| +12% | +$2.65M | 0.58% | 39 |
|
|
2024
Q4 | $21.6M | Sell |
329,021
-1,955
| -0.6% | -$131K | 0.42% | 59 |
|
|
2024
Q3 | $23.3M | Buy |
330,976
+278,744
| +534% | +$23.3M | 0.38% | 69 |
|
|
2024
Q2 | $4.3M | Sell |
52,232
-269,555
| -84% | -$22.4M | 0.07% | 98 |
|
|
2024
Q1 | $28.1M | Sell |
321,787
-3,989
| -1% | -$357K | 0.43% | 66 |
|
|
2023
Q4 | $31.4M | Sell |
325,776
-24,112
| -7% | -$2.13M | 0.48% | 63 |
|
|
2023
Q3 | $31M | Sell |
349,888
-10,716
| -3% | -$953K | 0.5% | 55 |
|
|
2023
Q2 | $31.3M | Buy |
360,604
+312,159
| +644% | +$29.4M | 0.45% | 65 |
|
|
2023
Q1 | $4.71M | Sell |
48,445
-12,240
| -20% | -$1.27M | 0.07% | 105 |
|
|
2022
Q4 | $6.28M | Buy |
60,685
+7,192
| +13% | +$675K | 0.08% | 107 |
|
|
2022
Q3 | $4.54M | Sell |
53,493
-20,260
| -27% | -$1.8M | 0.07% | 111 |
|
|
2022
Q2 | $6.11M | Sell |
73,753
-847
| -1% | -$67.4K | 0.09% | 110 |
|
|
2022
Q1 | $5.75M | Buy |
74,600
+3,200
| +4% | +$268K | 0.07% | 114 |
|
|
2021
Q4 | $6.31M | Buy |
71,400
+19,700
| +38% | +$1.63M | 0.07% | 120 |
|
|
2021
Q3 | $4M | Buy |
51,700
+11,200
| +28% | +$884K | 0.04% | 136 |
|
|
2021
Q2 | $3.38M | Buy |
40,500
+3,500
| +9% | +$277K | 0.03% | 137 |
|
|
2021
Q1 | $2.79M | Buy |
+37,000
| New | +$3.02M | 0.03% | 134 |
|
|
2020
Q3 | – | Sell |
-76,900
| Closed | -$9.48M | – | 218 |
|
|
2020
Q2 | $9.48M | Buy |
76,900
+4,800
| +7% | +$477K | 0.13% | 109 |
|
|
2020
Q1 | $6.09M | Buy |
72,100
+4,900
| +7% | +$422K | 0.12% | 110 |
|
|
2019
Q4 | $5.68M | Buy |
+67,200
| New | +$5.08M | 0.09% | 110 |
|
|
2019
Q1 | – | Sell |
-45,969
| Closed | -$3.91M | – | 140 |
|
|
2018
Q4 | $3.91M | Sell |
45,969
-1,900
| -4% | -$181K | 0.27% | 77 |
|
|
2018
Q3 | $4.64M | Sell |
47,869
-1,650
| -3% | -$165K | 0.29% | 74 |
|
|
2018
Q2 | $4.67M | Buy |
49,519
+5,169
| +12% | +$453K | 0.4% | 56 |
|
|
2018
Q1 | $3.6M | Sell |
44,350
-700
| -2% | -$60.1K | 0.36% | 58 |
|
|
2017
Q4 | $4.02M | Sell |
45,050
-3,750
| -8% | -$326K | 0.42% | 53 |
|
|
2017
Q3 | $4.54M | Sell |
48,800
-16,200
| -25% | -$1.43M | 0.48% | 56 |
|
|
2017
Q2 | $5.9M | Hold |
65,000
| – | – | 0.7% | 53 |
|
|
2017
Q1 | $5.71M | Hold |
65,000
| – | – | 0.76% | 46 |
|
|
2016
Q4 | $5.38M | Hold |
65,000
| – | – | 1.1% | 30 |
|
|
2016
Q3 | $6.01M | Hold |
65,000
| – | – | 1.09% | 34 |
|
|
2016
Q2 | $5.06M | Hold |
65,000
| – | – | 0.95% | 38 |
|
|
2016
Q1 | $5.36M | Buy |
+65,000
| New | +$5.29M | 0.97% | 36 |
|
Other funds holding BMRN
VCM
VPM
